documents: FDA-2026-P-5116-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-P-5116-0005 FDA FDA-2026-P-5116 Appendix III - Hangas A, Aasumets K, Kekäläinen NJ, Paloheinä M, Pohjoismäki JLO, Gerhold JM. Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2. Pharmacol Res. 2018;132:101–110. Supporting & Related Material Background Material 2026-05-11T04:00:00Z 2026 5     2026-05-11T23:22:14Z   0 0 09000064b92c88fd

Links from other tables